Neoadjuvant pyrotinib plus nab-paclitaxel, doxorubicin, and cyclophosphamide for HER2-positive locally advanced breast cancer: a retrospective case-series study
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.